(SMTX, PRXL, LCI) CRWENewswire Stocks In Action
On its Second Quarter Fiscal 2012, PAREXEL International Corp -PRXL - posted consolidated service revenue of $333.2 million, a 9.5% increase year over year. For the third quarter Fiscal 2012, PAREXEL expects to report consolidated service revenue in the range of $350 to $358 million. SMTC Corp - SMTX - reported the completion of a signed contract agreement to manufacture Alstom Transport’s leading edge transportation technology systems and products. Lannett Company Inc - LCI - reported that it has received approval from the FDA of its supplemental Abbreviated New Drug Application for Phentermine HCl Capsules, 15 mg. The company expects to commence shipping the product shortly. Phentermine Hydrochloride (HCl) is indicated for the short-term management of obesity.

******

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

ユーザー：karmastock
再生時間：00:01:25
投稿日時：12/02/01 4:21
カテゴリ：ビジネス全般 
タグ： PRXL  SMTX  LCI  Nasdaq:PRXL  Nasdaq:SMTX  Amex:LCI 

[ 前ページへ戻る ]